- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 13, 2025 | 3.27M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 2.62M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 1.79M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 185.92K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 80.71K sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$7.22M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$6.61M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $4.06M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $5.03M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.99M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $3.32M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $1.21M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $4.03M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $3.66M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $4.72M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $2.8M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $259K |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $2.76M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $1.64M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $2.79M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.71M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $4.7M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $5.62M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $4.78M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $5.74M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.28 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$5.19 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$11.42 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$77.55 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.28 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$5.19 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$11.42 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$77.55 |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $1.77M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $5.19M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $1.13M |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $2.86M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$3.36M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$9.3M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$2.89M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$3.05M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$2.12M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$6.26M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$2.25M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$1.89M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$3.37M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$9.31M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$2.13M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$6.28M |